John 2018

To caliotter3: Hopefully you have a good career and development with good behavior.

Please delete the whole topic. Best regards.

Thanks to the great contribution from SimpleClaudia. Your experience is excellent. As the aim to improve the public awareness of insulin administration safety was already achieved, please delete the whole topic.

To caliotter3: After someone found out your mistake in your answers, could you please self-reflect why you made that mistake?

The BSL values were specifically preset in the question, according to the table at page 3/126, from the website: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000308/WC500029441.pdf I posted the question here is to improve the public awareness of insulin administration safety, via sharing mutual experience. I don't need any answers.

To caliotter3: I recommend you to read the code of conduct and ethics. Please don't mislead others with inappropriate behavior. Your understanding about "withhold" is not good. Please don't mislead others to make wrong judgement. "withhold" and "delay" are totally different. There are two gold rules about insulin administration: 1. Do not withhold insulin due to previous hypoglycaemia. 2. If an insulin dose is due during a hypoglycaemic episode, it should be delayed until the hypoglycaemia has resolved, but not withheld.

To Julius Seizure, MSN You are reported regarding your illegal abuse on the allnurses forum. You are required by the law to self-disclose your illegal abuse to the nursing board. It is the law requirement. Regards

If you are confident to discuss any part of the question, you are welcome.

If you have something to share, you are welcome. If you don't have anything to share, please allow the opportunity for others to share. Thanks.

This question is a little bit more complex. Can anyone share your experience?

It is a great forum for others to share experience.

I believe you are a senior nurse with rich experience. The paragraph you wrote here is quite good, except two typos. One sentence from your paragraph, "if the dose she is getting is over 20 units and her BGL is It wouldn't be "withhold". It can be "delay". Another sentence from your paragraph, "if her BGL is 4 or 4.2 I will still withhold her dose." It wouldn't be "withhold". It can be "delay". Thanks.

Hi all, There is another question about Mixtard. The following example is a pre-set scenario: A patient is on Mixtard BD, before breakfast 08:00 and before dinner 17:00. At 07:30, if BSL is 4.0 mmol/L, what would you do? would you like to give Mixtard half hour before breakfast at 08:00? At 07:30, if BSL is 4.2 mmol/L, what would you do? At 07:30, if BSL is 4.6 mmol/L, what would you do? At 07:30, if BSL is 5.0 mmol/L, what would you do? Can anyone share your experience here? Thanks.

This question looks simple. However, it could be a little bit complex. My question established the opportunity for others to share experience. It is not a homework. I am a nurse.

Can anyone share your experience here?

Hi all, It is a great forum to share experience with others. The following example is a pre-set scenario: A patient is on NovoMix BD, before breakfast 08:00 and before dinner 17:00. At 07:30, if BSL is 4.0 mmol/L, what would you do? would like to give NovoMix half hour before breakfast at 08:00? At 07:30, if BSL is 4.2 mmol/L, what would you do? At 07:30, if BSL is 4.6 mmol/L, what would you do? At 07:30, if BSL is 5.0 mmol/L, what would you do? Can anyone share your experience here? Thanks.

Which state are you working in Australia? Did you check the policy framework? What is the policy requirement for each brand and each strength in Australia? If you search online with the following key words, "ward register", "separate page", "each brand name", and "each strength", perhaps you can find something.

In Australia, a separate page of the ward register should be used for each brand name and each strength generally. Also, facility policies need to be checked. How is the same scenario going in other countries such as New Zealand, Canada, UK and Ireland?

This question came from online research. It didn't come from practice. In other words, it is a scenario for others to share experiences together on the forum. Thanks.

For example, both brands have the same strength 10 mg. Should Oxycodone Sandoz Controlled release tablets 10 mg be documented on the same page as OxyContin Reformulated Modified release tablets 10 mg in the ward register? Or should Oxycodone Sandoz Controlled release tablets 10 mg be documented on a difference page ? In other words, Oxycodone Sandoz Controlled release tablets 10 mg to be documented on one page, and OxyContin Reformulated Modified release tablets 10 mg to be documented on another different page.

Can anybody help the following question? In Australia, Oxycondone controlled release has two different brands: Oxycodone Sandoz Controlled release tablets, 5 mg, 10 mg, 20 mg, 40 mg, 80 mg. OxyContin Reformulated Modified release tablets, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 80 mg. Above two brands contain the same medication Oxycondone controlled release , but with difference strengths. In the ward register, should a different brand use a different page? or should these two brands be mixed together as the same medication Oxycontin on the same page in the ward register? Please advise. Thanks.